-
Study aim
-
To evaluate effectiveness of intraoperative ketamine infusion vs magnesium sulphate infusions in reducing acute post operative pain in patients who have undergone unilateral knee replacement.
-
Design
-
Two arm, parallel group, randomized controlled trial with participant and outcome assessor blinding at a single center. Sixty four participants will be randomly allocated using the lottery method.
-
Settings and conduct
-
The study will be conducted at Evercare Hospital Lahore. Eligible participants will provide informed consent and undergo random allocation to ketamine or magnesium. Other anesthesia and perioperative medications will be standardized. Participants and the outcome assessor will be blinded.
-
Participants/Inclusion and exclusion criteria
-
Adults over 18 years scheduled for elective unilateral total knee replacement, of either sex, with American Society of Anesthesiologists physical status I to III, able to consent and report pain. Patients with contraindications to ketamine or magnesium, chronic pain, opioid dependence, relevant medication use, neurological disorders, pregnancy, uncontrolled cardiovascular disease, or severe hepatic or renal impairment will be excluded.
-
Intervention groups
-
The ketamine group will receive intravenous ketamine 0.5 mg/kg followed by 2 to 5 micrograms/kg/minute infusion during surgery. The magnesium group will receive magnesium sulfate 40 mg/kg before induction followed by 15 mg/kg infusion until skin closure.
-
Main outcome variables
-
The primary outcome is acute postoperative pain measured using the Numerical Rating Scale from 0 to 10 at 24 hours. Secondary outcomes include opioid consumption, adverse effects, time to rescue analgesia, and persistent postoperative pain at 6 months.